Regulatory Updates

Latest News

FDA Sets Review Date for Zoryve in Atopic Dermatitis
FDA Sets Review Date for Zoryve in Atopic Dermatitis

November 29th 2023

The FDA has set a date of July 07, 2024, for Zorvye 0.15% for adults and children six and up with the chronic skin disease atopic dermatitis.

ia-64-stock.adobe.com
FDA Issues Complete Response for Novel Dry Eye Therapy

November 28th 2023

source: Orexo
FDA Sets Review for Nasal Opioid Rescue Drug

November 28th 2023

Photo courtesy of SpringWorks Therapeutics
FDA Approves First Treatment for Rare Noncancerous Tumors

November 28th 2023

Generic News: New Approvals and New Research
Generic News: New Approvals and New Research

November 22nd 2023

Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.